Metabolomics as a Tool for Discovery – PLOS | ONE article
Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children
The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples offers an opportunity for development of diagnostic tests for detection of ASD at an early age.
Read the Full Publication
Posters & Publications
- RT @AutismDirectory: Everybody is different, including those who are on the autistic spectrum.#MythbustingMonday #MondayMotivation https:…3 days ago
- How can parents help children learn to manage their emotions? Here are some guidelines:https://t.co/cpmQRz11mx… https://t.co/zzvGn56YAG3 days ago
- It can be hard to tell if a child is experiencing #delayeddevelopment that could signal a condition like #autism.… https://t.co/Ln3JluZlRQ5 days ago